Sobel S, Cowan D
J Genet Couns. 2015; 9(3):237-51.
PMID: 26141319
DOI: 10.1023/A:1009416021896.
Soldan J, Street E, Gray J, Binedell J, Harper P
J Genet Couns. 2015; 9(1):15-31.
PMID: 26141082
DOI: 10.1023/A:1009425022687.
do Nascimento Marinho A, de Lima M, Vargas F
J Community Genet. 2015; 6(3):259-64.
PMID: 25994216
PMC: 4524832.
DOI: 10.1007/s12687-015-0235-3.
Surampalli A, Khare M, Kubrussi G, Wencel M, Tanaja J, Donkervoort S
J Genet Couns. 2015; 24(5):842-50.
PMID: 25716352
PMC: 5565393.
DOI: 10.1007/s10897-015-9819-7.
Crozier S, Robertson N, Dale M
J Genet Couns. 2014; 24(1):29-39.
PMID: 25236481
DOI: 10.1007/s10897-014-9755-y.
Genetic counseling for FTD/ALS caused by the C9ORF72 hexanucleotide expansion.
Fong J, Karydas A, Goldman J
Alzheimers Res Ther. 2012; 4(4):27.
PMID: 22808918
PMC: 3506941.
DOI: 10.1186/alzrt130.
When access is an issue: exploring barriers to predictive testing for Huntington disease in British Columbia, Canada.
Hawkins A, Creighton S, Hayden M
Eur J Hum Genet. 2012; 21(2):148-53.
PMID: 22781094
PMC: 3548262.
DOI: 10.1038/ejhg.2012.147.
Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis.
Fanos J, Gronka S, Wuu J, Stanislaw C, Andersen P, Benatar M
Genet Med. 2011; 13(4):342-8.
PMID: 21285887
PMC: 4039017.
DOI: 10.1097/GIM.0b013e318204d004.
Role of the disease in the psychological impact of pre-symptomatic testing for SCA2 and FAP ATTRV30M: Experience with the disease, kinship and gender of the transmitting parent.
Paneque M, Lemos C, Sousa A, Velazquez L, Fleming M, Sequeiros J
J Genet Couns. 2009; 18(5):483-93.
PMID: 19731000
DOI: 10.1007/s10897-009-9240-1.
Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey.
Bombard Y, Veenstra G, Friedman J, Creighton S, Currie L, Paulsen J
BMJ. 2009; 338:b2175.
PMID: 19509425
PMC: 2694258.
DOI: 10.1136/bmj.b2175.
Psychological follow-up of presymptomatic genetic testing for spinocerebellar ataxia type 2 (SCA2) in Cuba.
Paneque M, Lemos C, Escalona K, Prieto L, Reynaldo R, Velazquez M
J Genet Couns. 2007; 16(4):469-79.
PMID: 17318452
DOI: 10.1007/s10897-006-9083-y.
The perceived advantages and disadvantages of presymptomatic testing for Machado-Joseph disease: development of a new self-response inventory.
Rolim L, Zagalo-Cardoso J, Paul C, Sequeiros J, Fleming M
J Genet Couns. 2006; 15(5):375-91.
PMID: 17004133
DOI: 10.1007/s10897-006-9033-8.
Psychodynamic theory and counseling in predictive testing for Huntington's disease.
Tassicker R
J Genet Couns. 2005; 14(2):99-107.
PMID: 15959641
DOI: 10.1007/s10897-005-4066-y.
Psychological effect of genetic testing for Huntington's disease: an update of the literature.
Meiser B, Dunn S
West J Med. 2001; 174(5):336-40.
PMID: 11342513
PMC: 1071392.
DOI: 10.1136/ewjm.174.5.336.
Psychological impact of genetic testing for Huntington's disease: an update of the literature.
Meiser B, Dunn S
J Neurol Neurosurg Psychiatry. 2000; 69(5):574-8.
PMID: 11032605
PMC: 1763433.
DOI: 10.1136/jnnp.69.5.574.
Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer.
Aktan-Collan K, Mecklin J, de la Chapelle A, Peltomaki P, Uutela A, Kaariainen H
J Med Genet. 2000; 37(2):108-13.
PMID: 10662810
PMC: 1734517.
DOI: 10.1136/jmg.37.2.108.
Psychological functioning before predictive testing for Huntington's disease: the role of the parental disease, risk perception, and subjective proximity of the disease.
Decruyenaere M, Evers-Kiebooms G, Boogaerts A, Cassiman J, Cloostermans T, Demyttenaere K
J Med Genet. 1999; 36(12):897-905.
PMID: 10593997
PMC: 1734269.
Huntington's disease predictive testing: the case for an assessment approach to requests from adolescents.
Binedell J, Soldan J, Scourfield J, Harper P
J Med Genet. 1996; 33(11):912-8.
PMID: 8950670
PMC: 1050784.
DOI: 10.1136/jmg.33.11.912.
Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. The Canadian Collaborative Study Predictive Testing.
Lawson K, Wiggins S, Green T, Adam S, Bloch M, Hayden M
J Med Genet. 1996; 33(10):856-62.
PMID: 8933341
PMC: 1050767.
DOI: 10.1136/jmg.33.10.856.
Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.
Decruyenaere M, Evers-Kiebooms G, Boogaerts A, Cassiman J, Cloostermans T, Demyttenaere K
J Med Genet. 1996; 33(9):737-43.
PMID: 8880572
PMC: 1050726.
DOI: 10.1136/jmg.33.9.737.
